Marshall Wace North America’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-90,890
| Closed | -$7.26M | – | 1965 |
|
|
2021
Q1 | $7.26M | Buy |
90,890
+68,419
| +304% | +$5.46M | 0.03% | 465 |
|
|
2020
Q4 | $1.77M | Sell |
22,471
-16,146
| -42% | -$1.27M | 0.01% | 783 |
|
|
2020
Q3 | $1.7M | Buy |
+38,617
| New | +$1.7M | 0.01% | 638 |
|
|
2020
Q2 | – | Sell |
-3,308
| Closed | -$119K | – | 1611 |
|
|
2020
Q1 | $119K | Buy |
+3,308
| New | +$119K | ﹤0.01% | 973 |
|
|
2019
Q4 | – | Sell |
-1,832
| Closed | -$137K | – | 1730 |
|
|
2019
Q3 | $137K | Sell |
1,832
-1,068
| -37% | -$79.9K | ﹤0.01% | 1013 |
|
|
2019
Q2 | $234K | Buy |
2,900
+2,336
| +414% | +$188K | ﹤0.01% | 1014 |
|
|
2019
Q1 | $38K | Sell |
564
-21,481
| -97% | -$1.45M | ﹤0.01% | 1308 |
|
|
2018
Q4 | $1.64M | Buy |
22,045
+15,651
| +245% | +$1.17M | 0.02% | 475 |
|
|
2018
Q3 | $589K | Buy |
+6,394
| New | +$589K | ﹤0.01% | 684 |
|
|
2018
Q2 | – | Sell |
-10,236
| Closed | -$1.14M | – | 1841 |
|
|
2018
Q1 | $1.14M | Buy |
+10,236
| New | +$1.14M | 0.01% | 966 |
|
|
2017
Q3 | – | Sell |
-59,696
| Closed | -$4.66M | – | 1603 |
|
|
2017
Q2 | $4.66M | Buy |
59,696
+26,171
| +78% | +$2.04M | 0.03% | 522 |
|
|
2017
Q1 | $2.68M | Buy |
+33,525
| New | +$2.68M | 0.02% | 518 |
|